APA (7th ed.) Citation

AJM, M., KH, L., B, B., E, C., CJ, R., SR, R., . . . BC, C. (2022). The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer, 128(1), 169. https://doi.org/10.1002/cncr.33848

Chicago Style (17th ed.) Citation

AJM, Meijer, et al. "The Cumulative Incidence of Cisplatin-induced Hearing Loss in Young Children Is Higher and Develops at an Early Stage During Therapy Compared with Older Children Based on 2052 Audiological Assessments." Cancer 128, no. 1 (2022): 169. https://doi.org/10.1002/cncr.33848.

MLA (9th ed.) Citation

AJM, Meijer, et al. "The Cumulative Incidence of Cisplatin-induced Hearing Loss in Young Children Is Higher and Develops at an Early Stage During Therapy Compared with Older Children Based on 2052 Audiological Assessments." Cancer, vol. 128, no. 1, 2022, p. 169, https://doi.org/10.1002/cncr.33848.